skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
Sponsored by:

Scrip Awards Entry Deadline 1 July 2022

Now in its 18th year, the Scrip Awards brings together over 400 industry leaders to celebrate and recognise the very best innovations and achievements in global biopharma. Winners will be celebrated across 15 categories, covering a full spectrum of advancements, from Best New Drug, Community Partnership of the Year, Clinical Advance of the Year and Best Contract Research Organisation.

KEY DETAILS
  • Entries close 1 July 202
  • Ceremony 30 November 2022
  • Free to enter
  • Royal Lancaster, London

All Awards entries will be carefully reviewed by an independent Judging Panel - a group of senior industry experts from around the world, handpicked for their experience and objectivity. This prestigious annual event of networking and celebration will incorporate a gala black-tie dinner and Awards ceremony, on Wednesday 30 November at the Royal Lancaster Hotel, London.

The scrip categories 2022

Download All

Best New Drug Award

The Best New Drug Award recognises excellence in pharmaceutical development. Launching innovative new products is the most important function of the industry, and a successful new drug launch marks the culmination of years of risky and expensive R&D. In this category, the judges will be looking for the small molecule or biological product that was approved in its first market worldwide during the qualifying period that represents the best therapeutic advance in its area. All recently launched new active substances, including small-molecules, biologicals or vaccines, are eligible to enter as long as they were first licensed in any market between 1 June 2021 - 30 June 2022. Generic and biosimilar products are not eligible for this Award.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please give the trade and generic name of the entrant, the therapeutic indication for which it is being considered, and the company or companies involved in its development (if more than one company, please detail the relationship between the parties)
  • What was the date and market of the candidate’s first approval and launch?
  • Please explain the mechanism of action of the candidate. How does this represent a step forward in treatment in this therapeutic area?
  • Please outline the evidence for the product’s clinical activity. How does its activity translate into a meaningful therapeutic benefit for patients, and how is this benefit over and above that provided by other treatments in this area?
  • How does the entrant address an unmet medical need?
  • What is the potential market size of the candidate?

Who can Enter

Entrants must have played a role in the development of the nominated product, and all parties to joint ventures should be disclosed in the application.

Clinical Advance of the Year

This Award seeks to recognise success in a clinical trial of a new drug product (biological or chemical) which is expected to lead to an advance in healthcare. This might include the first demonstration of a clear clinical effect for a new drug in an area of unmet medical need, a pivotal study of a new drug with a breakthrough mechanism of action, or a major study of a potential new or expanded indication for an already marketed product. The product involved need not yet be approved, but the judges will be looking for innovation, clear proof of benefit and potential commercial reward. To be eligible, the study in question must have been presented for peer review at a major medical meeting or been published in a scientific journal between 1 June 2021 - 30 June 2022

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please give full details of the study, i.e., its name (protocol ID, trial identifier), phase, disease type and patients segment studied, sponsors, and the primary drug tested.
  • Please summarize the major findings of the study, including all primary/co-primary and main secondary endpoints, and safety endpoints.
  • How does the drug work in the setting tested?
  • How do these findings represent a potential leap forward in therapy, or fulfil an unmet medical need?
  • What could be the potential market size of this breakthrough?

Who can Enter

Entrants must have played a role in the clinical study, and all joint parties must be disclosed in the application.

WuXi AppTec’s Biotech Company of the Year

Sponsored by

The biotech industry’s entrepreneurial spirit and cutting-edge science have transformed the research and development of medicines in the past few decades. This Award honours outstanding achievement by biotech companies over the qualifying 12 months.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Name of entering company
  • What has been the company’s most significant achievement during the year?
  • Give details of what the firm has accomplished over the year in terms of:
  • Bringing new products closer to their first markets
    1. - Raising funds
    2. - Signing significant licensing or partnership deals
    3. - Showing strong management not afraid of making hard decisions
    4. - Using proprietary science or technologies to address an unmet medical need
    5. - Successfully transforming the business from an early stage to a more mature company

Who can Enter

The winner of the Biotech Company of the Year Award will be the biotech firm which has achieved the most in the 12 months between 1 June 2021 - 30 June 2022. For example, this could be moving the business from an early stage, to a more mature company, signing a transformative deal, taking its first or a major new product towards the market, or raising significant new funds.

China Biopharma Leadership Award

Scrip’s China Biopharma Leadership Award reflects on the rapid maturing of China’s biopharma sector - thanks to the development of Homegrown biopharma companies, CDMOs, and increasing investment from global multinational biopharma companies. The category seeks to reward firms that have shown leadership in developing China’s biopharma sector through significant commercial and R&D activity, and by helping patients access new treatments, through new launches and successful negotiations with China’s healthcare payers and clinical leaders.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please give the name of the entering company and the country where it is Headquartered.
  • What has been this company’s most significant achievement during the year?
  • Give details of what this company has achieved in terms of:
    1. - Growth in sales and profits
    2. - Signing important new deals
    3. - Introducing new products onto the market
    4. - Producing a promising new drug pipeline
    5. - Operational improvements, particularly after restructuring, or changing the focus of the business
    6. - Collaboration with government and regional authorities on patient access and healthcare modernization

Who can Enter

This Award is open to any research-based pharmaceutical company either headquartered in China or with a significant presence in the market through its own investment or via a major partnership.

The judges will be looking for excellent performance across business activities achieved between 1 June 2021 - 30 June 2022. This could include a range of leadership activities, from launching new products, or signing a transformative new commercial deal or working with Chinese authorities on innovation in healthcare and patient access.

Community Partnership of the Year

This Award is designed to acknowledge the numerous ways in which pharma and biotech companies give back to the wider community. This could include outreach within a local community, with a charity or patient advocacy group, or alongside an NGO or humanitarian organisation.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please give the name of the entering company and the name of the partnership
  • Please outline the nature of the partnership being entered
  • What were the aims of the partnership?
  • What were the benefits of the partnership and how were they measured?
  • What lessons were learned from the partnership and how might it be improved in future?

Who can Enter

The judges will be looking for effective partnership activity which took place between 1 June 2021 - 30 June 2022, to the benefit of humankind. For example, these types of partnerships could include patient and carer support programs, educational programs or disease awareness campaigns or even a social media campaign that went viral.

Executive of the Year

Scrip’s Executive of the Year Award is designed to acknowledge excellence in the leadership of large and small pharmaceutical and biotechnology companies.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please give the name, company and position of the entrant, and the date of taking up this post.
  • What have been the entrant’s greatest achievements during the qualifying year?
  • What has been the direct consequence of these on company performance?
  • How have these achievements strengthened the candidate’s influence within the industry? Please give examples.
  • What are the entrant’s greatest strengths as a leader? Please show how these have had a bearing on their achievements this year.
  • What specific previous accomplishments did the entrant have that made them perfectly fitted to achieving this success? For example, previous scientific or management experience.

Who can Enter

This year’s winner will be the executive who has exhibited exemplary leadership throughout the year from 1 June 2021 - 30 June 2022. This could range from leading an emerging company to an established place within the industry, to turning around the fortunes of a failing company or unit, or leading a firm successfully through the turbulence of a merger or acquisition. Also important to the judges will be the executive’s career achievements, influence within the industry and leadership qualities. To be eligible for this year’s Award, entrants must hold a C-suite executive position. Candidates must be employed by the company at the time of nomination.

Licensing Deal of the Year

Licensing is vital both in helping to keep pharma’s pipelines replenished and in generating income for smaller firms. Deals considered here are those that involve the licensing of a particular drug, project or group of drugs/projects from one company to another for further development and/ or marketing. Please note, it does not include more involved partnerships between companies to explore particular therapeutic strategies (see Criteria for the Best Partnership Alliance).

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please outline the structure of the deal, giving the names of the parties involved, the drug candidate(s) concerned, and what rights it covers.
  • What is the monetary value of the deal in up-front and milestone payments?
  • What is the geographic spread of the deal? Does it allow any party to enter new markets?
  • What is the strategic value of the licensed product to the licensee’s business?
  • Please explain how the licensed product was the best possible candidate to complement the rest of the licensee’s pipeline or particular disease franchise.

Who can Enter

In choosing the winner of Scrip’s Licensing Deal of the Year Award, the judges will look at all aspects of the submitted transactions, from their monetary and strategic value, to The benefits they give to both sides. To qualify, licensing deals must have been closed between 1 June 2021 - 30 June 2022.

Business Development Team of the Year

Scrip’s Business Development Team of the Year Award will honour the achievements of business development teams whether they are from a pharma or biotech company or a cross-company team responsible for a specific deal or collaborative project.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please give details of the company and companies, the particular team being entered and its core function.
  • Please describe the team’s goals and vision, and how these are communicated.
  • What was the greatest achievement of the team during the year between 1 June 2021 - 30 June 2022?
  • Please describe how all parts of the team were fully aligned to achieve this, including how supporting functions, such as HR, finance and IT, were integrated into the team.
  • Rate the team, giving justification, according to the following criteria:
    1. - Achieving short-term and long-term goals
    2. - Managing resources
    3. - Providing a platform for professional development and teamwork
    4. - How does the team embody a management model that others should follow?

Who can Enter

This Award will go to a team that is truly much more than the sum of its parts. The Judges will be looking for strong performance across a number of criteria, such as achievement of short and long-term goals, and good communication of a shared vision.

Best Contract Research Organisation – Full-Service Providers

The Award for the Best Contract Research Organization acknowledges the critical role that CROs play in drug development. Outsourcing is vital as the pharmaceutical industry seeks to benefit more and more from these specialist companies’ experience in handling all aspects of clinical trials and other research. This year the Award has been split into two categories to separate the full-service providers from those smaller CROs that provide specialist services to their clients. Today, the role of the CRO has gone beyond the traditional model of service-level agreements, to offer bespoke clinical trial and other strategies; and CROs are increasingly engaged in risk-sharing partnerships, or acting as a single-source developer, while also remaining committed to core strengths.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • What particular capabilities and strengths does the CRO offer?
  • How has this firm delivered results that exceed sponsor expectations?
  • What innovations in patient recruitment strategy has the CRO brought to its partner?
  • How has it improved its performance, for example, in its quality of data, timelines and transparency?
  • What steps is the company taking towards streamlining data collection and reporting?

Who can Enter

This Award is for the companies who provide the full range of services to their clients; and they will be judged on the quality of services and relationships they have built with their clients. It will pay particular attention to the innovative patient recruitment strategies the CRO has brought to the deal. To qualify, candidates must draw on their achievements in the year between 1 June 2021 - 30 June 2022.

Best Contract Research Organisation – Specialist Providers

The Award for the Best Contract Research Organisation acknowledges the critical role that CROs play in drug development. Outsourcing is vital as the pharmaceutical industry seeks to benefit more and more from these specialist companies’ experience in handling all aspects of clinical trials and other research. This year the Award has been split into two categories to separate the full-service providers from those smaller CROs that provide specialist services to their clients.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • What particular capabilities and strengths does the CRO offer?
  • How has this firm delivered results that exceed sponsor expectations?
  • What innovations has the CRO brought to its partner?
  • How has it improved its performance, for example, in its quality of data, timelines and transparency?
  • What steps is the company taking towards streamlining data collection and reporting?

Who can Enter

This Award for those companies who provide niche services to their clients will be judged on the quality of services and relationships they have built with their clients. To qualify, candidates must draw on their achievements in the year between 1 June 2021 - 30 June 2022.

Best Partnership Alliance

Scrip’s Best Partnership Alliance Award recognises the importance of pharmaceutical and/ or biotech companies working together to develop new medicines. This category seeks to reward innovative partnerships between companies in which they share the risks and rewards inherent in developing new drugs.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please give the name of the company or organisations involved.
  • Please outline the structure of the partnership, detailing the parties involved, what it covers and the responsibilities on both sides.
  • Does its structure represent an innovative business model, and if so how? How does it demonstrate that either party was the “partner of choice”?
  • Please summarize the strategic potential of the deal, and if applicable the milestone reached.
  • Please explain how the deal is mutually beneficial to both parties.
  • What aspect of the deal makes it unique or particularly special?
  • How does the collaboration hope to meet any unmet medical need?

Who can Enter

The judges will be focusing on deals that require strong strategic input from both partners, involving business development, joint marketing/promotion or joint R&D. They are looking for those deals that are the most mutually beneficial, have the most strategic potential, and are innovative in their structure. Partnerships must have been announced, or have achieved a significant milestone, between 1 June 2021 - 30 June 2022, and entrants should be able to show some sustained benefits from the deal. Please note, deals between majority or wholly owned subsidiaries and their parent companies are not eligible for this Award.

Financing Deal of the Year

This Scrip Award seeks to reward successful and creative fundraising by pharma and biotech companies. The investment can come in a variety of guises from grants and public private partnership deals to venture fundraising and public offerings, but should be earmarked for use in drug discovery and/or development. In making their decision, the judges will scrutinize entrants on their fundraising strategy, amount raised, the structure of the deal, and on how the money will be used.

WHAT YOU NEED TO KNOW

To enter this category, please answer the following:

  • Please outline the form of the financing, how much money was raised (including how this compares with the company’s capital base), and how close was this to meeting your fundraising objectives?
  • Please explain how this source of financing was best suited to your purposes.
  • Please describe how this fundraising was particularly creative. Has this set a precedent that has since been repeated?
  • Did the funding succeed in other ways, such as bringing on board a new kind of investor?
  • How will the money be used?
  • Please give evidence of early value creation from the deal.

Who can Enter

This award is open only to companies actually raising the funds (i.e., not bankers or agents). To be eligible, all financing must have been announced between 1 June 2021 - 30 June 2022

MSD’s Innovation Award

Sponsored By

This category will acknowledge and celebrate the outstanding scientific or technological breakthrough which the judging believes has the potential to be transformative in the discovery or development of new medicines.

WHAT YOU NEED TO KNOW

Entries will be judged on the answers to a number of key questions:

  • What is the scientific, technological or medical challenge they are targeting?
  • What is the solution to the challenge?
  • What proof of principle or concept has been achieved?
  • How will the entry impact either the discovery or development of innovative therapeutic approaches?
  • How novel is the innovation?

Who can Enter

The Award is open to any person, group or company that has achieved a genuinely Groundbreaking advance during the qualifying period of 1 June 2021 - 30 June 2022. We welcome entries that are active in the life sciences ecosystem – from early-stage research through to clinical proof-of-concept developments. Achievements we wish to recognise include: insights that advance our understanding of disease biology; new therapeutic targets or approaches; elucidation of a novel mechanism of action; clinical proof of concept of a novel mechanism or novel target; and techniques and technology platforms that enhance the medical benefits of new or existing medicines.

Pharma Company of the Year

Sponsored by

The Pharma Company of the Year Award honours outstanding achievements by pharmaceutical companies over the qualifying 12 months between 1 June 2021 - 30 June 2022.

WHAT YOU NEED TO KNOW

This special Award is chosen by Scrip’s senior editorial team, based on a variety of key metrics:

  • Financial performance in 2021 compared with the previous year
  • Strategic advances, looking at its most significant achievements over the year
  • Progress in the emerging markets
  • New product launches, including line-extensions and formulations
  • Advances in the drug pipeline, including major clinical trial reports

Lifetime Achievement Award

Sponsored by

The winner of this Award will be an exceptional individual with a consistent history of service, above and beyond the call of duty, throughout their career. This prestigious international Award will go to someone who has had a distinguished career in the biotech or pharmaceutical arena, primarily within industry.

WHAT YOU NEED TO KNOW

For this special Award, candidates must be nominated by a third party. The nomination should outline in no more than 750 words what the nominee has accomplished during his or her career and say why they are worthy of this Award.

All nominations must include:

  • Name of the nominee
  • Job title of the nominee (if applicable)
  • Company name (if applicable)
  • Your contact details
  • Contact details of the nominee
  • A précis of up to 750 words of why you think your nominee is worthy of receiving the Lifetime Achievement Award.

Who can Enter

Nominees may be retired or semi-retired but will still be active in the industry in some capacity. For this special Award, candidates must be nominated by a third party. The nomination should outline in no more than 750 words what the nominee has accomplished during his or her career and say why they are worthy of this Award.

The Judges

Enter Now

Ready to submit your entry to the Scrip Awards 2022? Enter today to be in with a chance of winning a prestigious Scrip Award

Enter Now

Want to sponsor an award?

Sponsorship provides a wealth of opportunities, from thought leadership, to brand awareness and lead generation. Find out more about the numerous sponsorship opportunities available.

Sponsor Opportunities

BOOK A TABLE

Looking to attend the Scrip Awards? Book your table today for the awards!

BOOK YOUR TABLE

Headline Sponsor

ICON plc is a world-leading healthcare intelligence and clinical research organisation, with over 38,000 employees in 93 locations in 46 countries around the world, headquartered in Dublin. We advance clinical research by providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device, and government and public health organisations. Our services span the entire lifecycle of product development, from molecule to medicine, across a broad range of therapeutic areas. We develop new innovations, drive emerging therapies forward, and improve patient lives.

our 2022 sponsors

MSD has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide. From MSD’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines. In 2019 MSD had sales of more than $46 billion and we operate in more than 140 countries.

Parexel partners with life science and biopharmaceutical customers across the globe to help transform scientific discoveries into innovative new therapies that improve patient health. Our full-service offerings span early phase to post-marketing approval and include expert consultation across regulatory and consulting, laboratory services, real-world evidence, market access and more. With more than 35 years of experience, our therapeutic, technical and functional abilities are underpinned by a deep conviction In what we do best: supporting our customers in fulfilling the unmet medical needs of patients worldwide.

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2021 and its open-access platform is enabling more than 5,600 collaborators from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."

PREVIOUS SCRIP AWARD CEREMONIES

The Scrip Awards are now in the 18th year of connecting hundreds of pioneers in global healthcare. Take a look back at our previous Awards and winners.

2021
Scrip Awards 2021

2nd December, 2021

2020
Scrip Awards 2020

Virtual ceremony 2020

2019
Scrip Awards 2019

4th December, 2019

got a question about the awards?

Please enter your name
Please enter your email
Please enter your valid email
Please enter your question
Please accept the terms & conditions
Senior Events Manager

jo.kirkpatrick@informa.com